NRC Health grows revenue 11%, but margin falls: healthcare AI has yet to show up on the bottom line

By Simply Wall St · October 29, 2026.

NRC Health posted revenue of $38.4 million in the third quarter of 2026, up 11% from $34.6 million in the same period of 2025, according to data compiled by Simply Wall St. Net income excluding extraordinary items was $4.7 million, up 18% from $4.0 million a year earlier. Basic earnings per share rose from $0.18 to $0.22.

The catch is operating profitability. The adjusted EBITDA margin (adjusted earnings before interest, taxes, depreciation and amortization) was 28%, down from roughly 31% a year earlier. The company attributes part of the decline to the timing of its HUB conference and says the next phase of its largest implementation will be smaller. The stock barely moved, edging up 0.09% to $23.49.

NRC Health provides analytics that help US healthcare organizations measure and improve the patient and employee experience. According to the article, total recurring contract value (TRCV) grew 9%, with gains in its Experience, Market Insights and Governance areas. It also mentions early pilots of Huey AI and the launch of nQuire Pro. The article does not explain exactly what each product does, so their scope shouldn't be overstated.

Our take: this quarter is a good example of where much of AI applied to healthcare stands today. There are commercial signals, such as customers buying tools and pilots under way, but operating leverage, meaning revenue growing faster than costs, has yet to show up. That makes sense: deploying, training and supporting customers costs money before any efficiency gains appear. Be careful, too, about blaming the entire margin decline on the conference. That is management's explanation, and only the coming quarters will show whether the dip is one-off or structural.

The figures matter beyond a share price. The case that AI will improve healthcare rests on modest companies that turn patient-experience data into operational decisions, not just on large diagnostic models. In the short term, that transition is slow and margins are tight. In the long term, if these tools prove they can link patient feedback to outcomes and savings, healthcare will become more efficient and more patient-centered. A small step, but in the right direction.

A word of caution: the source is a general financial analysis, not investment advice, and part of its narrative framing is the platform's own interpretation.